UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Worst Combination for Coronary Artery Disease Under Strong-Statin Therapy Is Chronic Kidney Disease and Diabetes　― Non-Lipid Residual Risk Assessment From the REAL-CAD Study

Circulation Journal, 2024/05/24, Vol.88(6), pp.1004-1006

Nohara, Atsushi

2024

Volltextzugriff (PDF)

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study

Journal of Atherosclerosis and Thrombosis, 2022/05/01, Vol.29(5), pp.567-570

Nohara, Atsushi

2022

Volltextzugriff (PDF)

Rare and Deleterious Mutations in ABCG5/ABCG8 Genes Contribute to Mimicking and Worsening of Familial Hypercholesterolemia Phenotype

Circulation Journal, 2019/08/23, Vol.83(9), pp.1917-1924

2019

Volltextzugriff (PDF)

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease

Journal of Atherosclerosis and Thrombosis, 2018/09/01, Vol.25(9), pp.783-789

2018

Volltextzugriff (PDF)

Homozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2021/07/01, Vol.28(7), pp.665-678

2021

Volltextzugriff (PDF)

Epicardial Adipose Tissue as a Predictor of Plaque Vulnerability in Patients With Mild Chronic Kidney Disease

Circulation Journal, 2015/12/25, Vol.80(1), pp.64-66

Nohara, Atsushi

2016

Volltextzugriff (PDF)

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017

Journal of Atherosclerosis and Thrombosis, 2018/08/01, Vol.25(8), pp.751-770

2018

Volltextzugriff (PDF)

Guidance for Pediatric Familial Hypercholesterolemia 2017

Journal of Atherosclerosis and Thrombosis, 2018/06/01, Vol.25(6), pp.539-553

2018

Volltextzugriff (PDF)

Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　– ODYSSEY JAPAN Randomized Controlled Trial

Circulation Journal, 2016/08/25, Vol.80(9), pp.1980-1987

2016

Volltextzugriff (PDF)

Clinical Diagnostic Criteria of Familial Hypercholesterolemia　― A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria

Circulation Journal, 2021/05/25, Vol.85(6), pp.891-897

2021

Volltextzugriff (PDF)

Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events

Journal of Atherosclerosis and Thrombosis, 2020/01/01, Vol.27(1), pp.38-46

2020

Volltextzugriff (PDF)

Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2016/01/06, Vol.23(1), pp.39-43

Nohara, Atsushi

2016

Volltextzugriff (PDF)

Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia

Circulation Journal, 2021/10/25, Vol.85(11), pp.2073-2078

2021

Volltextzugriff (PDF)

Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J

Journal of Atherosclerosis and Thrombosis, 2022/08/01, Vol.29(8), pp.1201-1212

2022

Volltextzugriff (PDF)

Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene

Journal of Atherosclerosis and Thrombosis, 2022/06/01, Vol.29(6), pp.816-824

2022

Volltextzugriff (PDF)

Validation of the 2022 Clinical Diagnostic Criteria of Familial Hypercholesterolemia in Japan

Journal of Atherosclerosis and Thrombosis, 2024/05/01, Vol.31(5), pp.550-558

2024

Volltextzugriff (PDF)

Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J

Journal of Atherosclerosis and Thrombosis, 2021/12/01, Vol.28(12), pp.1307-1322

2021

Volltextzugriff (PDF)

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Atherosclerosis, 2023-04, Vol.371, p.61-66

2023

Volltextzugriff (PDF)

Guidelines for the Management of Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2012, Vol.19(12), pp.1043-1060

2012

Volltextzugriff (PDF)

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies

Nutrients, 2018-11, Vol.10 (11), p.1789

2018

Volltextzugriff (PDF)

Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease

Journal of clinical lipidology, 2018-11, Vol.12 (6), p.1436-1444

2018

Volltextzugriff (PDF)

Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia

Circulation Journal, 2023/05/25, Vol.87(6), pp.806-812

2023

Volltextzugriff (PDF)

Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study

Journal of Atherosclerosis and Thrombosis, 2019/04/01, Vol.26(4), pp.368-377

2019

Volltextzugriff (PDF)

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks

Scientific reports, 2023-11, Vol.13 (1), p.19782-19782, Article 19782

2023

Volltextzugriff (PDF)

Monogenic, polygenic, and oligogenic familial hypercholesterolemia

Current opinion in lipidology, 2019-08, Vol.30 (4), p.300-306

2019

Volltextzugriff (PDF)

1 – 25 von 467

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(414)

Publikationsform

Sprache

Englisch
(440)
Japanisch
(159)

Erscheinungsjahr

n.n

Thema

Science & Technology
(270)
Life Sciences & Biomedicine
(255)
Humans
(182)
Male
(142)
Female
(110)
Middle Aged
(106)
Cardiovascular System & Cardiology
(95)
Aged
(80)
Adult
(71)
Familial Hypercholesterolemia
(64)
Peripheral Vascular Disease
(60)
Cardiac & Cardiovascular Systems
(54)
Japan
(45)
Biological And Medical Sciences
(37)
Oncology
(37)
Risk Factors
(37)
Mutation
(33)
Hyperlipoproteinemia Type Ii - Genetics
(30)
Medical Sciences
(29)
Urology & Nephrology
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Worst Combination for Coronary Artery Disease Under Strong-Statin Therapy Is Chronic Kidney Disease and Diabetes　― Non-Lipid Residual Risk Assessment From the REAL-CAD Study

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study

Rare and Deleterious Mutations in ABCG5/ABCG8 Genes Contribute to Mimicking and Worsening of Familial Hypercholesterolemia Phenotype

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease

Homozygous Familial Hypercholesterolemia

Epicardial Adipose Tissue as a Predictor of Plaque Vulnerability in Patients With Mild Chronic Kidney Disease

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017

Guidance for Pediatric Familial Hypercholesterolemia 2017

Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　– ODYSSEY JAPAN Randomized Controlled Trial

Clinical Diagnostic Criteria of Familial Hypercholesterolemia　― A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria

Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events

Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia

Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia

Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J

Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene

Validation of the 2022 Clinical Diagnostic Criteria of Familial Hypercholesterolemia in Japan

Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Guidelines for the Management of Familial Hypercholesterolemia

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies

Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease

Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia

Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks

Monogenic, polygenic, and oligogenic familial hypercholesterolemia

Aktive Filter

Suchergebnisse filtern